ACROBiosystem's PE-Labeled Human CD19 (20-291) Protein, His Tag

ACROBiosystem's PE-Labeled Human CD19 (20-291) Protein, His Tag is a PE-labeled human CD19 (aa 20–291, His-tag) produced in HEK293 cells using next-generation site-specific conjugation.

Synonym

CD19, B4, CVID3, MGC12802

Source

PE-Labeled Human CD19 (20-291), His Tag (CD9-HP2H5) is generated through the conjugation of PE to Human CD19 (20-291), His Tag utilizing an advanced site-specific technology within the Star Staining labeling platform. Human CD19 (20-291), His Tag is expressed in human 293 cells (HEK293). It comprises AA Pro 20 - Lys 291 (Accession # P15391-1).

Molecular characterization

ACROBiosystem

Image Credit: ACROBiosystems

This protein carries a polyhistidine tag at the C-terminus.

Conjugate

  • PE
  • Excitation Wavelength: 488 nm / 561 nm
  • Emission Wavelength: 575 nm

Formulation

Lyophilized from a solution filtered through a 0.22 μm membrane in PBS, containing 0.2 % BSA, at pH 7.4, with trehalose serving as a protectant.

Reconstitution

ACROBiosystems Inc., highly advises adhering to the reconstitution protocol outlined in the CoA to achieve optimal performance.

Storage

For extended storage, the product must be kept in a lyophilized state at -20 °C or below.

It should be shielded from light and should not undergo multiple freeze-thaw cycles.

This product remains stable after being stored at:

  • -70 °C for 3 months under sterile conditions after reconstitution.
  • -20 °C to -70 °C for 12 months in the lyophilized state.

ACRO Quality Management System

  • QMS (ISO, GMP)
  • Quality Advantages
  • Quality Control Process

Performance data

Evaluation of CAR expression

FACS analysis of anti-CD19 CAR expression

5e5 of anti-CD19 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human CD19 (20-291), His Tag (Cat. No. CD9-HP2H5) and negative control protein respectively (Fig. C and B), and non-transfected 293 cells were used as a control (Fig. A). PE signal was used to evaluate the binding activity (QC tested).

5e5 of anti-CD19 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human CD19 (20-291), His Tag (Cat. No. CD9-HP2H5) and negative control protein respectively (Fig. C and B), and non-transfected 293 cells were used as a control (Fig. A). PE signal was used to evaluate the binding activity (QC tested). Image Credit: ACROBiosystems

FACS analysis of non-specific binding to PBMCs

5e5 of PBMCs were stained with PE-Labeled Human CD19 (20-291), His Tag (Cat. No. CD9-HP2H5), and anti-CD3 antibody, washed, and then analyzed with FACS. FITC signal was used to evaluate the expression of CD3+ T cells in PBMCs, and PE signal was used to evaluate the non-specific binding activity to PBMCs (QC tested).

5e5 of PBMCs were stained with PE-Labeled Human CD19 (20-291), His Tag (Cat. No. CD9-HP2H5), and anti-CD3 antibody, washed, and then analyzed with FACS. FITC signal was used to evaluate the expression of CD3+ T cells in PBMCs, and PE signal was used to evaluate the non-specific binding activity to PBMCs (QC tested). Image Credit: ACROBiosystems

Other Equipment by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.